The chemical substance known as [[[(1S)-1-(4-Bromophenyl)ethyl]amino](1,2,3,4-tetrahydro-2,3-dioxo-5-quinoxalinyl)methyl] phosphonic acid tetrasodium salt is a complex organic compound characterized by its unique structural features, including a phosphonic acid moiety and a quinoxaline derivative. This compound is typically utilized in biochemical research and may exhibit properties such as enzyme inhibition or modulation of signaling pathways due to its ability to interact with biological targets. The presence of the bromophenyl group suggests potential hydrophobic interactions, while the phosphonic acid component may confer water solubility and ionic characteristics, particularly in its tetrasodium salt form. The compound's stereochemistry, indicated by the (1S) configuration, may influence its biological activity and interactions with receptors or enzymes. Overall, this substance represents a class of compounds that can be valuable in medicinal chemistry and pharmacological studies, although specific applications and mechanisms of action would require further investigation.

PEAQX, also known as NVP-AAM077; is a competitive antagonist at the NMDA receptor. Although originally described as 100-fold selective for GluN1/GluN2A receptors vs. GluN1/GluN2B receptors, more detailed studies of the Ki of PEAQX revealed it only shows a 5 fold difference in affinity for GluN1/GluN2A vs. GluN1/GluN2B receptors. It is also a potent anticonvulsant in animal tests.

[[[(1S)-1-(4-Bromophenyl)ethyl]amino](1,2,3,4-tetrahydro-2,3-dioxo-5-quinoxalinyl)methyl] phosphonic acid tetrasodium salt

2102348-87-6: The chemical substance known as [[[(1S)-1-(4-Bromophenyl)ethyl]amino](1,2,3,4-tetrahydro-2,3-dioxo-5-quinoxalinyl)methyl] phosphonic acid tetrasodium salt is a complex organic compound characterized by its unique structural features, including a phosphonic acid moiety and a quinoxaline derivative. This compound is typically utilized in biochemical research and may exhibit properties such as enzyme inhibition or modulation of signaling pathways due to its ability to interact with biological targets. The presence of the bromophenyl group suggests potential hydrophobic interactions, while the phosphonic acid component may confer water solubility and ionic characteristics, particularly in its tetrasodium salt form. The compound's stereochemistry, indicated by the (1S) configuration, may influence its biological activity and interactions with receptors or enzymes. Overall, this substance represents a class of compounds that can be valuable in medicinal chemistry and pharmacological studies, although specific applications and mechanisms of action would require further investigation.

<p>PEAQX (NVP-AAM077) is a competitive NMDA antagonist, mildly prefers GluN1/GluN2A to GluN2B, and acts as an anticonvulsant.</p>

CAS 2102348-87-6

[[[(1S)-1-(4-Bromophenyl)ethyl]amino](1,2,3,4-tetrahydro-2,3-dioxo-5-quinoxalinyl)methyl] phosphonic acid tetrasodium salt

PEAQX sodium

Ref: TM-T69906

NVP AAM 077 tetrasodium hydrate

Ref: 3D-FB65108